However, several more recent studies in pediatric and infant ALL have shown that, although a fundamental signature is shared by all MLL-r samples, translocation-specific gene expression profiles can be found, as well as the existence of patient subpopulations characterized by specific gene expression profiles, all of which points towards heterogeneity of the disease [41, 42]. The gene discussed is KMT2A; the disease is acute lymphoblastic leukemia.